Skip to main content
. 2019 Jun 19;2019:5859680. doi: 10.1155/2019/5859680

Figure 5.

Figure 5

Recurrence rates by combined EGFR/IL-1α scores. Shown are the percentage of tumors (a) and percentage of tumor recurrences (b) based on combined EGFR and IL-1α expression scores. Location of recurrences in 2/1/EGFR+ tumors are shown in (c).